Final efficacy results from IMpower132: First-line atezolizumab plus chemotherapy in patients with stage IV non-squamous NSCLC-MedSci.cn

Final efficacy results from IMpower132: First-line atezolizumab plus chemotherapy in patients with stage IV non-squamous NSCLC

Nishio, M; Barlesi, F; Ball, S; Bordoni, R; Cobo, M; Dubray-Longeras, P; Goldschmidt, J; Novello, S; Orlandi, FJ; Sanborn, R; Szalai, Z; Ursol, G; Mendus, D; Wang, L; Wen, X; McCleland, M; Hoang, T; Phan, S; Socinski, M

ANNALS OF ONCOLOGY, 2020; 31 (): S1386

科室
- - 订阅+
  - 更多科室
工具
服务

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Final efficacy results from IMpower132: First-line atezolizumab plus chemotherapy in patients with stage IV non-squamous NSCLC

科室

工具

服务